97 related articles for article (PubMed ID: 9336334)
1. Interaction between hyperthermia and oxygen radical formation in the 5-hydroxytryptaminergic response to a single methamphetamine administration.
Fleckenstein AE; Wilkins DG; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1997 Oct; 283(1):281-5. PubMed ID: 9336334
[TBL] [Abstract][Full Text] [Related]
2. Methamphetamine-induced rapid decrease in dopamine transporter function: role of dopamine and hyperthermia.
Metzger RR; Haughey HM; Wilkins DG; Gibb JW; Hanson GR; Fleckenstein AE
J Pharmacol Exp Ther; 2000 Dec; 295(3):1077-85. PubMed ID: 11082443
[TBL] [Abstract][Full Text] [Related]
3. Role of the 5-HT2 receptor in the methamphetamine-induced neurochemical alterations.
Johnson M; Sonsalla PK; Letter AA; Hanson GR; Gibb JW
J Pharmacol Exp Ther; 1994 Jul; 270(1):97-103. PubMed ID: 7913500
[TBL] [Abstract][Full Text] [Related]
4. Rapid and reversible effects of methamphetamine on dopamine transporters.
Fleckenstein AE; Metzger RR; Wilkins DG; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1997 Aug; 282(2):834-8. PubMed ID: 9262348
[TBL] [Abstract][Full Text] [Related]
5. Effect of flunarizine and nimodipine on the decrease in tryptophan hydroxylase activity induced by methamphetamine and 3,4-methylenedioxymethamphetamine.
Johnson M; Mitros K; Stone DM; Zobrist R; Hanson GR; Gibb JW
J Pharmacol Exp Ther; 1992 May; 261(2):586-91. PubMed ID: 1374469
[TBL] [Abstract][Full Text] [Related]
6. Exacerbation of methamphetamine-induced neurochemical deficits by melatonin.
Gibb JW; Bush L; Hanson GR
J Pharmacol Exp Ther; 1997 Nov; 283(2):630-5. PubMed ID: 9353379
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain.
Hotchkiss AJ; Gibb JW
J Pharmacol Exp Ther; 1980 Aug; 214(2):257-62. PubMed ID: 6104722
[TBL] [Abstract][Full Text] [Related]
8. The effects of methamphetamine on the production of free radicals and oxidative stress.
Yamamoto BK; Zhu W
J Pharmacol Exp Ther; 1998 Oct; 287(1):107-14. PubMed ID: 9765328
[TBL] [Abstract][Full Text] [Related]
9. Methamphetamine-induced rapid and reversible reduction in the activities of tryptophan hydroxylase and dopamine transporters: oxidative consequences?
Hanson GR; Gibb JW; Metzger RR; Kokoshka JM; Fleckenstein AE
Ann N Y Acad Sci; 1998 May; 844():103-7. PubMed ID: 9668668
[TBL] [Abstract][Full Text] [Related]
10. Methamphetamine-induced spectrin proteolysis in the rat striatum.
Staszewski RD; Yamamoto BK
J Neurochem; 2006 Mar; 96(5):1267-76. PubMed ID: 16417574
[TBL] [Abstract][Full Text] [Related]
11. Lobeline attenuates methamphetamine-induced changes in vesicular monoamine transporter 2 immunoreactivity and monoamine depletions in the striatum.
Eyerman DJ; Yamamoto BK
J Pharmacol Exp Ther; 2005 Jan; 312(1):160-9. PubMed ID: 15331654
[TBL] [Abstract][Full Text] [Related]
12. Methamphetamine-induced inhibition of mitochondrial complex II: roles of glutamate and peroxynitrite.
Brown JM; Quinton MS; Yamamoto BK
J Neurochem; 2005 Oct; 95(2):429-36. PubMed ID: 16086684
[TBL] [Abstract][Full Text] [Related]
13. Delta opioid peptide [D-Ala2,D-leu5]enkephalin blocks the long-term loss of dopamine transporters induced by multiple administrations of methamphetamine: involvement of opioid receptors and reactive oxygen species.
Tsao LI; Ladenheim B; Andrews AM; Chiueh CC; Cadet JL; Su TP
J Pharmacol Exp Ther; 1998 Oct; 287(1):322-31. PubMed ID: 9765353
[TBL] [Abstract][Full Text] [Related]
14. Methamphetamine decreases calcium-calmodulin dependent protein kinase II activity in discrete rat brain regions.
Suemaru J; Akiyama K; Tanabe Y; Kuroda S
Synapse; 2000 Jun; 36(3):155-66. PubMed ID: 10819896
[TBL] [Abstract][Full Text] [Related]
15. Relationship between methamphetamine-induced behavioral activation and hyperthermia.
Phelps G; Speaker HA; Sabol KE
Brain Res; 2010 Oct; 1357():41-52. PubMed ID: 20709036
[TBL] [Abstract][Full Text] [Related]
16. The effects of chronic administration of quetiapine on the methamphetamine-induced recognition memory impairment and dopaminergic terminal deficit in rats.
He J; Yang Y; Yu Y; Li X; Li XM
Behav Brain Res; 2006 Sep; 172(1):39-45. PubMed ID: 16712969
[TBL] [Abstract][Full Text] [Related]
17. Effect of methamphetamine on tryptophan hydroxylase activity: role of hyperthermia.
Fleckenstein AE
Eur J Pharmacol; 1997 Aug; 332(3):263-5. PubMed ID: 9300258
[TBL] [Abstract][Full Text] [Related]
18. Short-term effects of 2,4,5-trihydroxyamphetamine, 2,4,5-trihydroxymethamphetamine and 3,4-dihydroxymethamphetamine on central tryptophan hydroxylase activity.
Elayan I; Gibb JW; Hanson GR; Lim HK; Foltz RL; Johnson M
J Pharmacol Exp Ther; 1993 May; 265(2):813-8. PubMed ID: 8496826
[TBL] [Abstract][Full Text] [Related]
19. Augmentation of serotonin release by sustained exposure to MDMA and methamphetamine in rat organotypic mesencephalic slice cultures containing raphe serotonergic neurons.
Higuchi M; Suzuki Y; Yatani Y; Kitagawa Y; Nagayasu K; Shirakawa H; Nakagawa T; Kaneko S
J Neurochem; 2008 Sep; 106(6):2410-20. PubMed ID: 18662325
[TBL] [Abstract][Full Text] [Related]
20. Single or multiple injections of methamphetamine increased dopamine turnover but did not decrease tyrosine hydroxylase levels or cleave caspase-3 in caudate-putamen.
Pereira FC; Lourenço ES; Borges F; Morgadinho T; Ribeiro CF; Macedo TR; Ali SF
Synapse; 2006 Sep; 60(3):185-93. PubMed ID: 16739116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
